Improving cancer immunotherapy by targeting the STATe of MDSCs

Por de Haas, Nienke, de Koning, Coco, Spilgies, Lisanne, de Vries, I. Jolanda M., Hato, Stanleyson V.
Publicado no Oncoimmunology (2016)

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition

Por Tel, Jurjen, Koornstra, Rutger, de Haas, Nienke, van Deutekom, Vincent, Westdorp, Harm, Boudewijns, Steve, van Erp, Nielka, Di Blasio, Stefania, Gerritsen, Winald, Figdor, Carl G., de Vries, I. Jolanda M., Hato, Stanleyson V.
Publicado no J Transl Med (2016)

Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death

Por Di Blasio, Stefania, Wortel, Inge M. N., van Bladel, Diede A. G., de Vries, Laura E., Duiveman-de Boer, Tjitske, Worah, Kuntal, de Haas, Nienke, Buschow, Sonja I., de Vries, I. Jolanda M., Figdor, Carl G., Hato, Stanleyson V.
Publicado no Oncoimmunology (2016)

Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients

Por Wimmers, Florian, de Haas, Nienke, Scholzen, Anja, Schreibelt, Gerty, Simonetti, Elles, Eleveld, Marc J., Brouwers, Huberdina M. L. M., Beldhuis-Valkis, Marjo, Joosten, Irma, de Jonge, Marien I., Gerritsen, Winald R., de Vries, I. Jolanda M., Diavatopoulos, Dimitri A., Jacobs, Joannes F. M.
Publicado no Sci Rep (2017)

Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity

Por Hato, Stanleyson V., Figdor, Carl G., Takahashi, Susumu, Pen, Anja E., Halilovic, Altuna, Bol, Kalijn F., Vasaturo, Angela, Inoue, Yukie, de Haas, Nienke, Verweij, Dagmar, Van Herpen, Carla M.L., Kaanders, Johannes H., van Krieken, Johan H.J.M., Van Laarhoven, Hanneke W.M., Hooijer, Gerrit K.J., Punt, Cornelis J.A., Asai, Akira, de Vries, I. Jolanda M., Lesterhuis, W.J.
Publicado no Oncotarget (2017)